2-(Butyloxy)-8-(methyloxy)-9-[3-(2-piperidinyl)propyl]-9H-purin-6-amine → 2-{[(1S)-1-Methylbutyl]oxy}-8-(methyloxy)-9-[2-(3-piperidinyl)ethyl]-9H-purin-6-amine
반응식
C(OC1N=C2C(N=C(OC)N2CCCC2CCCCN2)=C(N)N=1)CCC.[NH2:27][C:28]1[N:36]=[C:35]([O:37][C@@H:38]([CH3:42])[CH2:39][CH2:40][CH3:41])[N:34]=[C:33]2[C:29]=1[N:30]=[C:31]([O:61][CH3:62])[N:32]2[CH2:43][CH2:44][CH:45]1[CH2:50][CH2:49][CH2:48][N:47](C(OCC2C=CC=CC=2)=O)[CH2:46]1>>[CH3:42][C@H:38]([O:37][C:35]1[N:34]=[C:33]2[C:29]([N:30]=[C:31]([O:61][CH3:62])[N:32]2[CH2:43][CH2:44][CH:45]2[CH2:50][CH2:49][CH2:48][NH:47][CH2:46]2)=[C:28]([NH2:27])[N:36]=1)[CH2:39][CH2:40][CH3:41]참가 물질
3
반응물 2
생성물 1
실험 절차
Prepared similarly to Intermediate 32 from phenylmethyl 3-{2-[6-amino-2-{[(1S)-1-methylbutyl]oxy}-8-(methyloxy)-9H-purin-9-yl]ethyl}-1-piperidinecarboxylate.
출처 및 근거
- ORD 기록
- ord-76bf9e12de3249188768d6da149ad39c